New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Most part D plans cover at least one biologic DMARD

Most part D plans cover at least one biologic DMARD

(HealthDay)—Although most Medicare Part D plans cover at least one biologic disease-modifying antirheumatic drug (DMARD), copayments are high, according to a study published in the June issue of
Arthritis and Rheumatism March 11,2024
Most part D plans cover at least one biologic DMARD

Most part D plans cover at least one biologic DMARD

(HealthDay)—Although most Medicare Part D plans cover at least one biologic disease-modifying antirheumatic drug (DMARD), copayments are high, according to a study published in the June issue of
Arthritis and Rheumatism March 11,2024
Gout flare-ups rise sharply with certain foods: study

Gout flare-ups rise sharply with certain foods: study

Research found more attacks after high consumption of compounds called purines, especially from meat, seafood.(HealthDay) -- Meat, seafood and other foods rich in compounds called purines are associat
Arthritis and Rheumatism March 11,2024
Gout flare-ups rise sharply with certain foods: study

Gout flare-ups rise sharply with certain foods: study

Research found more attacks after high consumption of compounds called purines, especially from meat, seafood.(HealthDay) -- Meat, seafood and other foods rich in compounds called purines are associat
Arthritis and Rheumatism March 11,2024
ACR: TNF inhibitors linked to reduced risk of ACS in RA

ACR: TNF inhibitors linked to reduced risk of ACS in RA

For patients with rheumatoid arthritis, tumor necrosis factor inhibitor treatment correlates with reductions in the risk of acute coronary syndromes and myocardial infarction, according to two studies
Arthritis and Rheumatism March 11,2024
ACR: TNF inhibitors linked to reduced risk of ACS in RA

ACR: TNF inhibitors linked to reduced risk of ACS in RA

For patients with rheumatoid arthritis, tumor necrosis factor inhibitor treatment correlates with reductions in the risk of acute coronary syndromes and myocardial infarction, according to two studies
Arthritis and Rheumatism March 11,2024
Oral bisphosphonate use cuts risk of post-implant revision Sx

Oral bisphosphonate use cuts risk of post-implant revision Sx

(HealthDay)—For patients undergoing total joint replacement, oral bisphosphonate use is associated with a reduction in the risk of revision surgery, according to a study published in the November issu
Arthritis and Rheumatism March 11,2024
Oral bisphosphonate use cuts risk of post-implant revision Sx

Oral bisphosphonate use cuts risk of post-implant revision Sx

(HealthDay)—For patients undergoing total joint replacement, oral bisphosphonate use is associated with a reduction in the risk of revision surgery, according to a study published in the November issu
Arthritis and Rheumatism March 11,2024
Novel susceptibility loci identified for osteoarthritis

Novel susceptibility loci identified for osteoarthritis

Five novel single nucleotide polymorphisms are significantly associated with osteoarthritis, including one near the nucleostemin-encoding gene, according to a study published online July 3 inThe
Arthritis and Rheumatism March 11,2024
Novel susceptibility loci identified for osteoarthritis

Novel susceptibility loci identified for osteoarthritis

Five novel single nucleotide polymorphisms are significantly associated with osteoarthritis, including one near the nucleostemin-encoding gene, according to a study published online July 3 inThe
Arthritis and Rheumatism March 11,2024
Meta-analysis: Oral contraceptive use not linked to RA onset

Meta-analysis: Oral contraceptive use not linked to RA onset

(HealthDay)—Oral contraceptive (OC) use does not appear to be associated with the risk of rheumatoid arthritis (RA), although there is an inverse association between OC use and RA severity, according
Arthritis and Rheumatism March 11,2024
Meta-analysis: Oral contraceptive use not linked to RA onset

Meta-analysis: Oral contraceptive use not linked to RA onset

(HealthDay)—Oral contraceptive (OC) use does not appear to be associated with the risk of rheumatoid arthritis (RA), although there is an inverse association between OC use and RA severity, according
Arthritis and Rheumatism March 11,2024
Recommendations for managing pain in inflammatory arthritis

Recommendations for managing pain in inflammatory arthritis

(HealthDay)—Recommendations have been developed for the management of pain in adults with optimally treated inflammatory arthritis, according to an article published in the September issue of the&nbsp
Arthritis and Rheumatism March 11,2024
Recommendations for managing pain in inflammatory arthritis

Recommendations for managing pain in inflammatory arthritis

(HealthDay)—Recommendations have been developed for the management of pain in adults with optimally treated inflammatory arthritis, according to an article published in the September issue of the&nbsp
Arthritis and Rheumatism March 11,2024
Prevalence of fibromyalgia varies with criteria applied

Prevalence of fibromyalgia varies with criteria applied

(HealthDay)—The prevalence of fibromyalgia varies with the different sets of the American College of Rheumatology (ACR) classification criteria, according to a study published in the February issue of
Arthritis and Rheumatism March 11,2024
Prevalence of fibromyalgia varies with criteria applied

Prevalence of fibromyalgia varies with criteria applied

(HealthDay)—The prevalence of fibromyalgia varies with the different sets of the American College of Rheumatology (ACR) classification criteria, according to a study published in the February issue of
Arthritis and Rheumatism March 11,2024
Modified ACR criteria effective for fibromyalgia diagnosis

Modified ACR criteria effective for fibromyalgia diagnosis

(HealthDay)—The 2011 modification of the 2010 American College of Rheumatology (ACR) preliminary criteria for the diagnosis of fibromyalgia (2011ModCr) has acceptable diagnostic accuracy compared with
Arthritis and Rheumatism March 11,2024
Modified ACR criteria effective for fibromyalgia diagnosis

Modified ACR criteria effective for fibromyalgia diagnosis

(HealthDay)—The 2011 modification of the 2010 American College of Rheumatology (ACR) preliminary criteria for the diagnosis of fibromyalgia (2011ModCr) has acceptable diagnostic accuracy compared with
Arthritis and Rheumatism March 11,2024
Short-term UV radiation linked to odds of juvenile myositis

Short-term UV radiation linked to odds of juvenile myositis

Short-term ultraviolet radiation exposure may contribute to the development of juvenile myositis, according to a study published in the July issue ofArthritis & Rheumatism.(HealthDay)—Short-
Arthritis and Rheumatism March 11,2024
Short-term UV radiation linked to odds of juvenile myositis

Short-term UV radiation linked to odds of juvenile myositis

Short-term ultraviolet radiation exposure may contribute to the development of juvenile myositis, according to a study published in the July issue ofArthritis & Rheumatism.(HealthDay)—Short-
Arthritis and Rheumatism March 11,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com